Fox, C P <br/><br/>
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2014 
 - 280-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2013.170  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Cohort Studies<br/>Epstein-Barr Virus Infections--drug therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunotherapy<br/>Lymphoproliferative Disorders--virology<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Retrospective Studies<br/>Rituximab<br/>Survival Analysis<br/>Transplantation Conditioning--adverse effects<br/>Viral Load